InvestorsHub Logo
Followers 74
Posts 9167
Boards Moderated 0
Alias Born 04/25/2002

Re: TraderAI post# 33219

Friday, 09/30/2022 3:44:12 PM

Friday, September 30, 2022 3:44:12 PM

Post# of 36582
Mrpenny.... recent events certainly cast some very dark shawdows! Tiny biotechs tend to be very volatile, and they die a very slow death with the investor pain lingering for several years. However, I'm not quite there yet with RVVTF. They are trying to navigate new FDA hurdles, and we'll see how effective they can do that. RLFTF was unsuccessful with navigating those FDA hurdles and that stock pps finally tanked.

There is still some hope left for RVVTF IMO. But as I've posted many times, I don't believe MIchael Frank is very effective at driving this boat, and he's had his priorities all screwed up from the very beginning IMO. He's a shroom guy. Several years ago I also discovered that Michael has been associated with performing a R/S with another company. So as the O/S and float grow with RVVTF, I do fear he'll eventually resort to that as a means to help raise funds. Time will tell.